T 0252/19 (Immunisation of large mammals/GlaxoSmithKline Biologicals) of 06.02.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T025219.20230206
- Date of decision
- 6 February 2023
- Case number
- T 0252/19
- Petition for review of
- -
- Application number
- 11736497.6
- IPC class
- A61K 39/00C12N 15/86
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Immunisation of large mammals with low doses of RNA
- Applicant name
- GlaxoSmithKline Biologicals SA
- Opponent name
- Janssen Vaccines & Prevention B.V.
Bayer Intellectual Property GmbH/Bayer Pharma
Aktiengesellschaft/Bayer Animal Health GmbH
Müller, Christian Stefan Gerd - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)European Patent Convention Art 116(1)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
- Cited cases
- T 0073/84
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.